These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18325859)

  • 61. Body dysmorphic disorder.
    Fang A; Matheny NL; Wilhelm S
    Psychiatr Clin North Am; 2014 Sep; 37(3):287-300. PubMed ID: 25150563
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Body dysmorphic disorder: diagnosis and treatment.
    Herren C; Armentrout T; Higgins M
    Gen Dent; 2003; 51(2):164-6. PubMed ID: 15055690
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Psychopathologic aspects of body dysmorphic disorder: a literature review.
    Pavan C; Simonato P; Marini M; Mazzoleni F; Pavan L; Vindigni V
    Aesthetic Plast Surg; 2008 May; 32(3):473-84. PubMed ID: 18224271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.
    Conroy M; Menard W; Fleming-Ives K; Modha P; Cerullo H; Phillips KA
    Gen Hosp Psychiatry; 2008; 30(1):67-72. PubMed ID: 18164943
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.
    Phillips KA; Siniscalchi JM; McElroy SL
    Psychiatr Q; 2004; 75(4):309-20. PubMed ID: 15563049
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An open-label trial of venlafaxine in body dysmorphic disorder.
    Allen A; Hadley SJ; Kaplan A; Simeon D; Friedberg J; Priday L; Baker BR; Greenberg JL; Hollander E
    CNS Spectr; 2008 Feb; 13(2):138-44. PubMed ID: 18227745
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.
    Phillips KA
    CNS Spectr; 2002 Jun; 7(6):453-60, 463. PubMed ID: 15107767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mental Disorders: Obsessive-Compulsive Disorder and Body Dysmorphic Disorder.
    Morgan S
    FP Essent; 2020 Aug; 495():17-22. PubMed ID: 32757562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cognitive behavior group therapy for body dysmorphic disorder: a case series.
    Wilhelm S; Otto MW; Lohr B; Deckersbach T
    Behav Res Ther; 1999 Jan; 37(1):71-5. PubMed ID: 9922559
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Body Dysmorphic Disorder.
    Jassi A; Krebs G
    Psychiatr Clin North Am; 2023 Mar; 46(1):197-209. PubMed ID: 36740353
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Body dysmorphic disorder: clinical aspects and treatment strategies.
    Phillips KA
    Bull Menninger Clin; 1998; 62(4 Suppl A):A33-48. PubMed ID: 9810776
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gender similarities and differences in 200 individuals with body dysmorphic disorder.
    Phillips KA; Menard W; Fay C
    Compr Psychiatry; 2006; 47(2):77-87. PubMed ID: 16490564
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thirty-three cases of body dysmorphic disorder in children and adolescents.
    Albertini RS; Phillips KA
    J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):453-9. PubMed ID: 10199118
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomised controlled trials of psychological & pharmacological treatments for body dysmorphic disorder: A systematic review.
    Phillipou A; Rossell SL; Wilding HE; Castle DJ
    Psychiatry Res; 2016 Nov; 245():179-185. PubMed ID: 27544783
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Imagined ugliness: a symptom which can become a disorder.
    Castle DJ; Morkell D
    Med J Aust; 2000 Aug; 173(4):205-7. PubMed ID: 11008595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
    Abbas S; Chandra PS; Srivastava M
    J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
    [No Abstract]   [Full Text] [Related]  

  • 77. Weight concerns in individuals with body dysmorphic disorder.
    Kittler JE; Menard W; Phillips KA
    Eat Behav; 2007 Jan; 8(1):115-20. PubMed ID: 17174859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.
    Fischer P; Tauscher J; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Mar; 13(2):83-6. PubMed ID: 9669189
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The problem of delusional ugliness: is it really body dysmorphic disorder?
    Fontenelle LF; Mendlowicz MV; Kalaf J; Versiani M
    World J Biol Psychiatry; 2006; 7(2):110-5. PubMed ID: 16684683
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial.
    Wilhelm S; Phillips KA; Didie E; Buhlmann U; Greenberg JL; Fama JM; Keshaviah A; Steketee G
    Behav Ther; 2014 May; 45(3):314-27. PubMed ID: 24680228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.